ICW Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

ICW Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$744K	Buy	1,513 +83	+6%	+$45K	0.27%	106
2025 Q4	$829K	Buy	1,430 +10	+0.7%	+$5.66K	0.3%	99
2025 Q3	$689K	Buy	1,420 +156	+12%	+$72.6K	0.25%	113
2025 Q2	$513K	Buy	1,264 +161	+15%	+$67.3K	0.2%	119
2025 Q1	$549K	Buy	1,103 +16	+1%	+$8.67K	0.22%	116
2024 Q4	$566K	Buy	1,087 +129	+13%	+$70.9K	0.24%	115
2024 Q3	$593K	Buy	958 +41	+4%	+$24.3K	0.25%	112
2024 Q2	$507K	Sell	917 -12	-1%	-$6.88K	0.23%	115
2024 Q1	$540K	Buy	929 +17	+2%	+$9.54K	0.24%	113
2023 Q4	$484K	Buy	912 +44	+5%	+$21.3K	0.24%	112
2023 Q3	$439K	Buy	868 +184	+27%	+$98K	0.24%	110
2023 Q2	$357K	Buy	684 +80	+13%	+$43.2K	0.19%	115
2023 Q1	$349K	Buy	604 +16	+3%	+$9.02K	0.2%	115
2022 Q4	$324K	Buy	588 +19	+3%	+$10.1K	0.19%	114
2022 Q3	$289K	Buy	569 +6	+1%	+$3.36K	0.19%	114
2022 Q2	$306K	Buy	563 +3	+0.5%	+$1.65K	0.19%	116
2022 Q1	$331K	Buy	560 +22	+4%	+$12.6K	0.19%	118
2021 Q4	$359K	Buy	538 +110	+26%	+$68.7K	0.2%	117
2021 Q3	$245K	Buy	+428	New	+$235K	0.16%	127

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

ICW Investment Advisors's TMO Position: Q1 2026 in Review

ICW Investment Advisors increased its Thermo Fisher Scientific (TMO) stake by 5.8% in Q1 2026, buying an estimated $45K and bringing the position to 1,513 shares worth $744K. The position accounts for 0.27% of the portfolio, ranked #106.

ICW Investment Advisors first reported a position in TMO in Q3 2021 and has held it in 19 quarters since. The position peaked at $829K in Q4 2025. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

ICW Investment Advisors held 1,513 shares of Thermo Fisher Scientific worth $744K as of Q1 2026.
ICW Investment Advisors bought 83 Thermo Fisher Scientific shares in Q1 2026, an estimated $45K.
Thermo Fisher Scientific made up 0.27% of ICW Investment Advisors's portfolio in Q1 2026, its #106 holding.
ICW Investment Advisors first reported a position in Thermo Fisher Scientific in Q3 2021 and has held it in 19 quarters since.
ICW Investment Advisors's Thermo Fisher Scientific position peaked at $829K in Q4 2025.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on ICW Investment Advisors's 13F filing for Q1 2026, filed 11 May 2026.